Deutsche Bank Ag\ Omeros Corp Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Omeros Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 28,978 shares of OMER stock, worth $316,149. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,978

Previous 23,787 21.82%

Holding current value

$316,149

Previous $96,000 19.79%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.54 - $5.47 $18,376 - $28,394	5,191 Added 21.82%	28,978 $115,000
Q2 2024 Aug 14, 2024	SELL	$3.04 - $4.23 $13,920 - $19,369	-4,579 Reduced 16.14%	23,787 $96,000
Q1 2024 May 15, 2024	SELL	$2.88 - $4.89 $3,150 - $5,349	-1,094 Reduced 3.71%	28,366 $97,000
Q3 2023 Nov 09, 2023	SELL	$2.81 - $5.69 $15,868 - $32,131	-5,647 Reduced 16.09%	29,460 $86,000
Q2 2023 Aug 14, 2023	BUY	$4.45 - $7.57 $65,054 - $110,665	14,619 Added 71.35%	35,107 $190,000
Q1 2023 May 15, 2023	SELL	$2.48 - $5.22 $74,400 - $156,600	-30,000 Reduced 59.42%	20,488 $95,000
Q4 2022 Feb 13, 2023	SELL	$1.75 - $3.96 $8,750 - $19,800	-5,000 Reduced 9.01%	50,488 $114,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $7.46 $108,150 - $261,100	-35,000 Reduced 38.68%	55,488 $175,000
Q2 2022 Aug 11, 2022	SELL	$1.92 - $6.28 $140,419 - $459,287	-73,135 Reduced 44.7%	90,488 $249,000
Q1 2022 May 13, 2022	SELL	$5.07 - $7.2 $22,713 - $32,256	-4,480 Reduced 2.67%	163,623 $983,000
Q4 2021 Feb 11, 2022	SELL	$5.67 - $8.54 $1.44 Million - $2.17 Million	-254,327 Reduced 60.21%	168,103 $1.08 Million
Q3 2021 Nov 04, 2021	BUY	$13.4 - $16.3 $110,536 - $134,458	8,249 Added 1.99%	422,430 $5.82 Million
Q2 2021 Aug 11, 2021	BUY	$14.81 - $19.13 $2.84 Million - $3.67 Million	191,881 Added 86.32%	414,181 $6.15 Million
Q1 2021 May 13, 2021	SELL	$14.52 - $23.53 $3,412 - $5,529	-235 Reduced 0.11%	222,300 $3.96 Million
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $406,360 - $608,739	-40,075 Reduced 15.26%	222,535 $3.18 Million
Q3 2020 Nov 12, 2020	BUY	$9.57 - $21.32 $407,481 - $907,784	42,579 Added 19.35%	262,610 $2.65 Million
Q2 2020 Aug 13, 2020	BUY	$12.21 - $16.99 $118,974 - $165,550	9,744 Added 4.63%	220,031 $3.24 Million
Q1 2020 May 14, 2020	SELL	$9.03 - $19.72 $120,433 - $263,005	-13,337 Reduced 5.96%	210,287 $2.81 Million
Q4 2019 Feb 14, 2020	BUY	$13.01 - $17.15 $377,303 - $497,367	29,001 Added 14.9%	223,624 $3.15 Million
Q3 2019 Nov 14, 2019	SELL	$14.55 - $20.56 $563,550 - $796,329	-38,732 Reduced 16.6%	194,623 $3.18 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.62 $90,075 - $117,818	6,005 Added 2.64%	233,355 $3.66 Million
Q1 2019 May 15, 2019	BUY	$11.65 - $17.72 $1.94 Million - $2.95 Million	166,615 Added 274.33%	227,350 $3.95 Million
Q4 2018 Feb 14, 2019	SELL	$10.72 - $16.73 $535,067 - $835,044	-49,913 Reduced 45.11%	60,735 $675,000
Q3 2018 Dec 21, 2021	BUY	$17.73 - $26.69 $337,242 - $507,670	19,021 Added 20.76%	110,648 $2.7 Million
Q3 2018 Nov 14, 2018	SELL	$17.73 - $26.69 $207,636 - $312,566	-11,711 Reduced 11.33%	91,627 $2.24 Million
Q2 2018 Apr 21, 2020	BUY	$10.79 - $24.44 $250,533 - $567,472	23,219 Added 28.98%	103,338 $1.88 Million
Q2 2018 Aug 14, 2018	BUY	$10.79 - $24.44 $120,319 - $272,530	11,151 Added 16.17%	80,119 $1.45 Million
Q1 2018 Oct 18, 2019	BUY	$9.0 - $20.16 $182,025 - $407,736	20,225 Added 41.49%	68,968 $769,000
Q1 2018 May 15, 2018	SELL	$9.0 - $20.16 $514,494 - $1.15 Million	-57,166 Reduced 53.98%	48,743 $543,000
Q4 2017 Feb 14, 2018	BUY	$13.26 - $22.86 $768,350 - $1.32 Million	57,945 Added 120.81%	105,909 $2.06 Million
Q3 2017 Nov 14, 2017	BUY	$19.76 - $24.9 $947,768 - $1.19 Million	47,964	47,964 $1.04 Million

Others Institutions Holding OMER

# of Institutions

120

Shares Held

25.6M

Call Options Held

228K

Put Options Held

630K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account